Raphas Co., Ltd. (KOSDAQ:214260)

Market Cap	133.19B
Revenue (ttm)	28.04B
Net Income (ttm)	-4.45B
Shares Out	8.41M
EPS (ttm)	-502.80
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,898
Average Volume	48,353
Open	16,000
Previous Close	15,970
Day's Range	15,850 - 16,140
52-Week Range	9,300 - 31,500
Beta	1.17
RSI	39.33
Earnings Date	Aug 14, 2025

About Raphas

Raphas Co., Ltd. manufactures and sells biodegradable microneedles in Korea. The company offers skin care, medical device, whitening care, and wrinkle care under the Acropass brand; and health food product under the FitKong brand. It also supplies double-layer microneedle manufacturing technology; and provides original development manufacturing, and contract development and manufacturing organization services. The company was founded in 2006 and is headquartered in Seoul, South Korea.

• Industry: Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 2006
• Employees: 79
• Stock Exchange: KOSDAQ
• Ticker Symbol: 214260

Financial Performance

In 2024, Raphas's revenue was 27.22 billion, a decrease of -2.58% compared to the previous year's 27.94 billion. Losses were -4.77 billion, -45.80% less than in 2023.